| Active substance | DapoxetineVardenafil |
|---|---|
| Active Half-Life | 36 hours |
| Classification | SSRI & PDE5 inhibitor |
| Dosage | Men 40-80 mg/day |
| Acne | No |
| Water Retention | No |
| HBR | Possible |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Not specific, general health checks may monitor effects |
| Also known as | Levitra |
| WAREHOUSE | International Warehouse 1 |
| Blood pressure | Can cause a transient decrease in blood pressure |
| Trade name | Levitra, Staxyn |
| Storage conditions | Store at room temperature between 15В°C and 30В°C (59В°F and 86В°F) |
| Chemical name | Vardenafil hydrochloride |
| Formula | C23H32N6O4SВ·HCl |
| Substance class | Phosphodiesterase type 5 inhibitor |
| Main action | Enhances erectile function by increasing blood flow to the penis |
| Half-life | 4.5 hours |
| Dosage (medical) | 10 mg taken orally approximately 60 minutes before sexual activity, adjustable based on efficacy and tolerability |
| Dosage (sports) | Not applicable |
| Effects | Improved erectile function and response to sexual stimulation |
| Side effects | Headache, flushing, nasal congestion, dyspepsia, dizziness |
| Use in sports | None, not applicable |
| Manufacturer | Centurion Laboratories |
Related products
Erection drugs
Erection drugs
Erection drugs
Erection drugs
Erection drugs
Erection drugs
Erection drugs
Erection drugs